Publications by authors named "Grigory V Volchenkov"

Claim this Profile
I
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Julia V Ershova, Grigory V Volchenkov, Tatiana R Somova, Tatiana A Kuznetsova, Natalia V Kaunetis

BMC Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.
Aditya Sharma, Andrew Hill, Ekaterina Kurbatova, Martie van der Walt, Charlotte Kvasnovsky, Grigory V Volchenkov

Lancet Infect Dis· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
J Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, Jeannette Brand, Julia Ershova, Grigory V Volchenkov

Clin Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
Courtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, Janice Campos Caoili, Martie Van Der Walt, Grigory V Volchenkov

PLoS Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
Julia V Ershova, Grigory V Volchenkov, Dorothy A Kaminski, Tatiana R Somova, Tatiana A Kuznetsova

Emerg Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Ekaterina V Kurbatova, Tracy Dalton, Julia Ershova, Thelma Tupasi, Janice Campos Caoili, Grigory V Volchenkov

Emerg Infect Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.
J Peter Cegielski, Michael P Chen, Thelma E Tupasi, Vaira Leimane, Grigory V Volchenkov

Clin Infect Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
J Peter Cegielski, Tracy Dalton, Martin Yagui, Wanpen Wattanaamornkiet, Grigory V Volchenkov

Clin Infect Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Tracy Dalton, Peter Cegielski, Somsak Akksilp, Luis Asencios, Janice Campos Caoili, Grigory V Volchenkov

Lancet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis